197 related articles for article (PubMed ID: 21274957)
1. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
2. Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.
Atrián-Blasco E; Conte-Daban A; Hureau C
Dalton Trans; 2017 Oct; 46(38):12750-12759. PubMed ID: 28937157
[TBL] [Abstract][Full Text] [Related]
3. Metal Binding of Alzheimer's Amyloid-β and Its Effect on Peptide Self-Assembly.
Abelein A
Acc Chem Res; 2023 Oct; 56(19):2653-2663. PubMed ID: 37733746
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Summers KL; Roseman G; Schilling KM; Dolgova NV; Pushie MJ; Sokaras D; Kroll T; Harris HH; Millhauser GL; Pickering IJ; George GN
Inorg Chem; 2022 Sep; 61(37):14626-14640. PubMed ID: 36073854
[TBL] [Abstract][Full Text] [Related]
5. Catalytic Mechanism of Amyloid-β Peptide Degradation by Insulin Degrading Enzyme: Insights from Quantum Mechanics and Molecular Mechanics Style Møller-Plesset Second Order Perturbation Theory Calculation.
Lai R; Tang WJ; Li H
J Chem Inf Model; 2018 Sep; 58(9):1926-1934. PubMed ID: 30133282
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional backbone modified squaramide dipeptides as amyloid beta (Aβ) aggregation inhibitors.
Dattatray Shinde S; Kumar Behera S; Kulkarni N; Dewangan B; Sahu B
Bioorg Med Chem; 2024 Jan; 97():117538. PubMed ID: 38056379
[TBL] [Abstract][Full Text] [Related]
7. The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design.
Tundo GR; Grasso G; Persico M; Tkachuk O; Bellia F; Bocedi A; Marini S; Parravano M; Graziani G; Fattorusso C; Sbardella D
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892174
[TBL] [Abstract][Full Text] [Related]
8. Studies on the interactions of copper and zinc ions with β-amyloid peptides by a surface plasmon resonance biosensor.
Yao F; Zhang R; Tian H; Li X
Int J Mol Sci; 2012; 13(9):11832-11843. PubMed ID: 23109885
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin-degrading enzyme in human neurons promotes amyloid-β deposition.
Rowland HA; Moxon SR; Corbett NJ; Hanson K; Fisher K; Kellett KAB; Hooper NM
Neuronal Signal; 2023 Dec; 7(4):NS20230016. PubMed ID: 37808160
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.
Saido TC
Proc Jpn Acad Ser B Phys Biol Sci; 2013; 89(7):321-39. PubMed ID: 23883611
[TBL] [Abstract][Full Text] [Related]
11. Numerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses.
Goch W; Bal W
PLoS One; 2017; 12(1):e0170749. PubMed ID: 28125716
[TBL] [Abstract][Full Text] [Related]
12. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer's disease and brain aging.
Corraliza-Gomez M; Bermejo T; Lilue J; Rodriguez-Iglesias N; Valero J; Cozar-Castellano I; Arranz E; Sanchez D; Ganfornina MD
J Neuroinflammation; 2023 Oct; 20(1):233. PubMed ID: 37817156
[TBL] [Abstract][Full Text] [Related]
13. Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity.
Ramaraju B; Nelson SL; Zheng W; Ghirlando R; Deshmukh L
Biochemistry; 2021 Aug; 60(33):2519-2523. PubMed ID: 34342986
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.
Malito E; Hulse RE; Tang WJ
Cell Mol Life Sci; 2008 Aug; 65(16):2574-85. PubMed ID: 18470479
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent DNA condensation induced by amyloid beta-peptide.
Yu H; Ren J; Qu X
Biophys J; 2007 Jan; 92(1):185-91. PubMed ID: 17028131
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease & metals: therapeutic opportunities.
Kenche VB; Barnham KJ
Br J Pharmacol; 2011 May; 163(2):211-9. PubMed ID: 21232050
[TBL] [Abstract][Full Text] [Related]
17. Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide.
Lv Z; Condron MM; Teplow DB; Lyubchenko YL
J Neuroimmune Pharmacol; 2013 Mar; 8(1):262-73. PubMed ID: 23143330
[TBL] [Abstract][Full Text] [Related]
18. Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1.
Schilling MA
J Alzheimers Dis; 2016; 51(4):961-77. PubMed ID: 26967215
[TBL] [Abstract][Full Text] [Related]
19. A coumarin-based multifunctional chemosensor for Cu
Kou X; Hu C; Pang Z; Zhang X; Wang H; Shen R; Yang A
Anal Chim Acta; 2023 Oct; 1279():341818. PubMed ID: 37827640
[TBL] [Abstract][Full Text] [Related]
20. Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.
Sparks DL; Friedland R; Petanceska S; Schreurs BG; Shi J; Perry G; Smith MA; Sharma A; Derosa S; Ziolkowski C; Stankovic G
J Nutr Health Aging; 2006; 10(4):247-54. PubMed ID: 16886094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
